INTRODUCTION
Klippel-Trénaunay-Weber syndrome (KTWS) is characterized by a set of signs that
consist of capillary malformations, venous malformations with or without
lymphatic malformations associated with limb overgrowth1. In most cases, it involves only one extremity with
arteriovenous malformation and approximately 75% of patients manifest the
disease before 10 years of age2,3.
Klippel-Trenaunay syndrome was first described by Maurice Klippel and Paul
Trenaunay. They reported two cases that had the triad (port wine stain, varices
and bone and soft tissue hypertrophy) in common4. Some time later, Frederick Weber described some cases presenting
a similarity to the triad, with the presence of arteriovenous fistula as an
association3,4. SKTW and Parkes Weber’s Syndrome may be
considered together as Klippel-Trenaunay-Weber sd because they present different
clinical signs of a single disease5,6.
KTWS is a rare congenital mesodermal disorder, with about 1000 cases recorded
worldwide7. KTWS is distributed
equally among the various ethnic groups and affects more men, at a ratio of
1.5:17,8. The etiology of this syndrome remains
unknown, although there are some theories of its pathogenesis9.
Although KTWS is a sporadic condition, studies have reported familial cases of
KTWS that were not inherited through a Mendelian pattern, suggesting a
multifactorial inheritance, with variable penetration and expression. Subsequent
studies conducted by Happle suggest that the inheritance of a single defective
gene acquired during embryogenesis could explain the development of this
syndrome, as well as the occurrence of sporadic and familial cases, suggesting
that an autosomal dominant inheritance is most likely10,11.
Clinically, KTWS comprises flat hemangioma, venous changes such as malformations
and varicose veins, and bone and soft tissue hypertrophy. 12,13
The diagnosis is clinical and can be performed by the presence of the triad of
abnormalities, or only two signs of the triad.
Usually, the patients with port wine stains, from birth, mainly in hypertrophied
limbs, varying in depth14. Venous
malformations affect the lower limbs in the vast majority of cases. Arterial or
venous angiodysplasia may be present in any region of the body, from the skin to
the visceral organs. Therefore, there is the possibility of phlebitis, bleeding,
deep venous thrombosis, pulmonary embolism, hemoperitoneum, hemothorax and
chronic venous insufficiency15.
It is a rare syndrome, but deserves to be highlighted due to progressive and
severe morbidity.
CASE REPORT
D.A.P., 7 months old, male, born and resident in Anápolis-GO, was forwarded to
our service in the Emergency Room of the Hospital de Clínicas, Federal
University of Uberlândia, MG, on 12/29/2014 with fever, vomiting, diarrhea and
dehydration for 2 days. Together with this presentation, he presented a giant
hemangioma in the left lower limb, varicose veins and hypertrophy of bone and
soft tissues (KTWS) (Figure 1) with a
history of recent laser treatment in another service of Goiânia-GO and with
propranolol.
Figure 1 - Giant hemangioma, varicose veins and bone and soft tissue
hypertrophy in the lower left limb.
Figure 1 - Giant hemangioma, varicose veins and bone and soft tissue
hypertrophy in the lower left limb.
The patient progressed rapidly and severely with necrosis of the left lower limb
(LLL) up to the ipsilateral gluteal region and with refractory septic shock
(Figure 2). He received intensive ICU
treatment with vasopressor drugs and broad spectrum antibiotic therapy for 28
days. Arterial and venous echo Doppler was performed during assessment of
vascular surgery, confirming the diagnosis of Klippel-Trénaunay-Weber syndrome
and identifying arteriovenous malformation and small fistulas of the left limb.
However, extensive necrotic lesion in the LLL remained, requiring, primarily,
surgical debridement of the LLL and subsequently left hip disarticulation with
protective colostomy on 01/28/2015.
Figura 2 - Presence of infection and necrotic tissue around the lower left
limb up to the ipsilateral gluteal region.
Figura 2 - Presence of infection and necrotic tissue around the lower left
limb up to the ipsilateral gluteal region.
After 2 months of intensive clinical treatment, clinical and topical improvement
of the lesion was observed in the postoperative region of the
disarticulation(Figure 3A), and skin
grafting was performed with electric dermatome and Mash Graft for occlusion of
the bloody wound (Figure 3B), with the
donor area of the right thigh. The patient presented good clinical recovery and
epithelialization of the recipient and donor area, being discharged on the
15th postoperative day(Figure 3C).
Figure 3 - A: Bloody area after left hip disarticulation;
B: Immediate postoperative aspect of mesh skin
graft; C: 15 day postoperative aspect of receiving
area.
Figure 3 - A: Bloody area after left hip disarticulation;
B: Immediate postoperative aspect of mesh skin
graft; C: 15 day postoperative aspect of receiving
area.
The patient has been in outpatient follow up in this service, progressing
satisfactorily with complete epithelialization of the donor and recipient areas.
The protective colostomy has been closed with the reconstruction of the
intestinal transit.
DISCUSSION
This study was motivated by having received a patient referring prior treatment
in another Plastic Surgery service with conservative treatment of KTWS with
laser. Such conduct maintained the patient incapacitated, suffering with
symptoms of chronic venous stasis and evolved with complications of local skin
infection until receiving the final treatment.
There is no curative treatment, and the therapeutic goals are intended to improve
the patient’s symptoms and correcting the consequences of serious injuries and
length discrepancy. However, all authors agree that conservative measures
continue to guide the treatment of KTWS. This does not rule out the need for
timely surgical interventions during the evolution of the natural history of the
disease.
Adjuvant therapies can vary from laser therapy, with microfoam sclerotherapy,
staged resections of ectatic veins and even larger excisions1,16-19 . The most
commonly used indications for surgical treatment are: hemorrhage, local
infections, thromboembolism and the occurrence of very refractory leg ulcers.
Other indications are: local pain, functional limitations and aesthetics17.
Interventional radiotherapy plays a major role in the propaedeutics of
arteriovenous malformations (AVMs). Through it, one can evaluate the type of
malformation and how the feeding vessels are structured. For the treatment of
low flow AVM (KTWS), in some cases an injection of sclerosing agent may be
applied to make the vessels smaller.
In other cases, this can be done using fluoroscopy. There are limited options for
treatment of congenital venous dysplasia. In severe cases, the interventionist
can use surgical removal, sclerotherapy or an endovascular ablation technique.
If there are symptoms in the skin, such as Port wine stains, laser treatment may
be indicated.
In cases such as the one described, considering the treatment performed, the area
covered by grafting can be seen as a good reconstructive option, taking into
account the simplicity of the procedure, less morbidity when compared to the use
of flaps and the possibility of rehabilitation through the use of
prostheses.
Despite being the highest level of lower limb amputation, the prosthesis is
efficient, since the prosthesis for this level of amputation provides security
and stability, with continuous gait, with or without locomotion aids, depending
on other factors including the age of the patient.
KTWS should be suspected in all newborns with capillary malformations involving
one extremity of the body from birth. The differential diagnosis for KTWS is
Proteus syndrome and Maffucci syndrome, among other non-syndromic capillary
malformations20.
Major advances will be made when it is possible to diagnose KTWS even more early
and prevent the development of tissue hypertrophy, complex angiodysplasias and
other phenotypic changes, perhaps by correcting or preventing the related
genetic mutation20.
CONCLUSION
KTWS is a rare disease, with progressive and severe morbidity. The patient with
this syndrome must be accompanied in a reference center with experience and a
diverse therapeutic arsenal to act in the best possible way in the treatment.
Each patient has the parsimony and individualization in choosing the best
treatment, as well as the ideal time to accomplish it.
Currently, the indication for surgical intervention is restricted to the
complications arising from the initial presentation. In this case, the use of
surgical treatment was crucial to allow an improvement in clinical condition and
quality of life of the patient, showing that it can be a valid alternative.
COLLABORATIONS
VPB
|
Writing the manuscript or critical review of its contents.
|
AOM
|
Analysis and/or interpretation of data; writing the manuscript or
critical review of its contents.
|
REFERENCES
1. Villela ALC, Guedes LGS, Paschoa VVA, David AB, Tenório TM, Lamego
Junior HP, et al. Perfil epidemiológico de 58 portadores de síndrome de
Klippel-Trénaunay-Weber acompanhados no Ambulatório da Santa Casa de São Paulo.
J Vasc Bras. 2009;8(3):219-24. DOI: http://dx.doi.org/10.1590/S1677-54492009000300006
2. Favorito LA. Vesical Hemangioma in patient with
Klippel-Trenaunay-Weber syndrome. J Urol. 2003;29(2):149-50.
3. Tonsgard JH, Fasullo M, Windle ML, McGovern M, Petry PD, Buehler B.
Klippel-Trenaunay-Weber Syndrome [Internet]. Pediatrics: General Medicine
Articles 2006. Disponível em: http://www.emedicine.com/derm/topic213.htm
4. Klippel M, Trénaunay P. Du naevus variqueux osteohypertrophique.
Arch Gen Med (Paris). 1900;185:641-72.
5. Weber FP. Haemangiectatic hypertrophy of limbs: congenital
phlebarteriectasis and so-called congenital varicose veins. Br J Child Dis.
1918;15:13-7.
6. Kihiczak GG, Meine JG, Schwartz RA, Janniger CK. Klippel-Trenaunay
syndrome: a multisystem disorder possibly resulting from a pathogenic gene for
vascular and tissue overgrowth. Int J Dermatol. 2006;45(8):883-90. PMID:
16911369 DOI: http://dx.doi.org/10.1111/j.1365-4632.2006.02940.x
7. Berry SA, Peterson C, Mize W, Bloom K, Zachary C, Blasco P, et al.
Klippel-Trenaunay syndrome. Am J Med Genet. 1998;79(4):319-26. PMID: 9781914
DOI: http://dx.doi.org/10.1002/(SICI)1096-8628(19981002)79:4<319::AID-AJMG15>3.0.CO;2-U
8. Capraro PA, Fisher J, Hammond DC, Grossman JA. Klippel-Trenaunay
syndrome. Plast Reconstr Surg. 2002;109(6):2052-60; quiz 2061-2. DOI: http://dx.doi.org/10.1097/00006534-200205000-00041
9. Meine JG, Schwartz RA, Janniger CK. Klippel-Trenaunay-Weber
syndrome. Cutis. 1997;60(3):127-32. PMID: 9314616
10. Lorda-Sanchez I, Prieto L, Rodriguez-Pinilla E, Martinez-Frias ML.
Increased parental age and number of pregnancies in Klippel-Trenaunay-Weber
syndrome. Ann Hum Genet. 1998;62(Pt 3):235-9. DOI: http://dx.doi.org/10.1046/j.1469-1809.1998.6230235.x
11. Hergesell K, Kröger K, Petruschkat S, Santosa F, Herborn C, Rudofsky
G. Klippel-Trenaunay syndrome and pregnancy. Int Angiol.
2003;22(2):194-8.
12. Wang QK. Update on the molecular genetics of vascular anomalies.
Lymphat Res Biol. 2005;3(4):226-33. DOI: http://dx.doi.org/10.1089/lrb.2005.3.226
13. Delis KT, Gloviczki P, Wennberg PW, Rooke TW, Driscoll DJ.
Hemodynamic impairment, venous segmental disease, and clinical severity scoring
in limbs with Klippel-Trenaunay syndrome. J Vasc Surg. 2007;45(3):561-7. PMID:
17275246 DOI: http://dx.doi.org/10.1016/j.jvs.2006.11.032
14. Viljoen D, Saxe N, Pearn J, Beighton P. The cutaneous manifestations
of the Klippel-Trenaunay-Weber syndrome. Clin Exp Dermatol. 1987;12(1):12-7.
DOI: http://dx.doi.org/10.1111/j.1365-2230.1987.tb01845.x
15. Kihiczak GG, Meine JG, Schwartz RA, Janniger CK. Klippel-Trenaunay
syndrome: a multisystem disorder possibly resulting from a pathogenic gene for
vascular and tissue overgrowth. Int J Dermatol. 2006;45(8):883-90. PMID:
16911369 DOI: http://dx.doi.org/10.1111/j.1365-4632.2006.02940.x
16. Lindenauer SM. The Klippel-Trenaunay Syndrome: Varicosity,
Hypertrophy and Hemangioma With No Arteriovenous Fistula. Ann Surg.
1965;162(2):303-4. DOI: http://dx.doi.org/10.1097/00000658-196508000-00023
17. Gloviczki P, Driscoll DJ. Klippel-Trenaunay syndrome: current
management. Phlebology. 2007;22(6):291-8. DOI: http://dx.doi.org/10.1258/026835507782655209
18. Frasier K, Giangola G, Rosen R, Ginat DT. Endovascular
radiofrequency ablation: a novel treatment of venous insufficiency in
Klippel-Trenaunay patients. J Vasc Surg. 2008;47(6):1339-45. DOI: http://dx.doi.org/10.1016/j.jvs.2008.01.040
19. Delis KT, Gloviczki P, Wennberg PW, Rooke TW, Driscoll DJ.
Hemodynamic impairment, venous segmental disease, and clinical severity scoring
in limbs with Klippel-Trenaunay syndrome. J Vasc Surg. 2007;45(3):561-7. PMID:
17275246 DOI: http://dx.doi.org/10.1016/j.jvs.2006.11.032
20. Garzon MC, Huang JT, Enjolras O, Frieden IJ. Vascular malformations.
Part II: associated syndromes. J Am Acad Dermatol. 2007;56(4):541-64. PMID:
17367610
1. Universidade Federal de Uberlândia, Uberlândia,
MG, Brazil.
Corresponding author: Victor Parreira
Bizinoto, Av. Mato Grosso, nº 3395, apt. 202 - Umuarama - Uberlândia, MG,
Brazil. Zip Code 38405-314. E-mail:
victorpbizinoto@hotmail.com
Article received: November 26, 2017.
Article accepted: September 5, 2018.
Conflicts of interest: none.